Literature DB >> 23684125

Time interval required for return to baseline of the background rhythm on electroencephalogram after recorded electrographic seizures.

Dimitrios Arkilo1, Sonya Wang, Elizabeth A Thiele.   

Abstract

Our objective was to assess the time interval that is required for the return to baseline of the background rhythm in the electroencephalogram (EEG) after ictal electrographic activity. We completed a retrospective EEG review of 28 adults and 13 children admitted to the epilepsy monitoring unit at Massachusetts General Hospital. EEG background rhythm on admission was considered the baseline rhythm per patient. In children the maximum time interval that was required for background rhythm to return to its baseline was 300 min, with average time of 120 min compared to a maximum of 420 min, with average time of 84 min for adults. Background slowing was shorter for frontal lobe seizures and longer for temporal lobe seizures. This study of patients with epilepsy shows that the time required for postictal slowing to resolve is short, and on average background rhythm returns to baseline within 2 h.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Background slowing; EEG; Electroencephalogram; Electrographic seizures; electroencephalogram

Mesh:

Year:  2013        PMID: 23684125     DOI: 10.1016/j.eplepsyres.2013.04.007

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  2 in total

1.  Diagnostic Puzzle of Acute Ischemic Stroke Mimics - Seizure Versus Post-Stroke Recrudescence: A Case Report.

Authors:  Femi Akindotun Akintomide; Reza Hosseini; Claudia Candale-Radu; Khurshid Khan
Journal:  Am J Case Rep       Date:  2022-07-01

2.  Ictal and preictal power changes outside of the seizure focus correlate with seizure generalization.

Authors:  Jason S Naftulin; Omar J Ahmed; Giovanni Piantoni; Jean-Baptiste Eichenlaub; Louis-Emmanuel Martinet; Mark A Kramer; Sydney S Cash
Journal:  Epilepsia       Date:  2018-06-13       Impact factor: 5.864

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.